|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general, and administrative expense | |||||
| Underwriting fees related to offering of common stock | |||||
| Amortization | |||||
| Income from operations | |||||
| Other expense: | |||||
| Interest expense, net | |||||
| Loss on extinguishment of debt | |||||
| Other (income) expense, net | |||||
| Total other expense, net | |||||
| Earnings from equity method investment | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) | |||||
| Net income (loss) per share attributable to common stockholders: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted-average common shares outstanding – basic and diluted | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
